MSD Pharmaceuticals Private Limited
MSD Pharmaceuticals Private Limited, commonly known as MSD, is a leading player in the pharmaceutical industry, headquartered in India. Established in 2003, the company has made significant strides in various operational regions, focusing on innovative healthcare solutions that cater to diverse medical needs. Specialising in prescription medicines, vaccines, and biologics, MSD is renowned for its commitment to research and development, which has led to the introduction of unique therapies in areas such as oncology, infectious diseases, and immunology. The company’s robust pipeline and strategic partnerships have solidified its market position, making it a trusted name in the healthcare sector. With a strong emphasis on quality and patient-centric solutions, MSD Pharmaceuticals continues to achieve notable milestones, contributing to improved health outcomes across India and beyond.
DitchCarbon Score
How does MSD Pharmaceuticals Private Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MSD Pharmaceuticals Private Limited's score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MSD Pharmaceuticals Private Limited's reported carbon emissions
MSD Pharmaceuticals Private Limited, headquartered in India, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or commitments to climate initiatives. This lack of information suggests that MSD Pharmaceuticals may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability and carbon neutrality, it will be essential for MSD Pharmaceuticals to establish clear climate commitments and reduction targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MSD Pharmaceuticals Private Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
